Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital
Sponsor: Mohamed Nasr
Summary
Prevelance of axial spondylosis arthritis in inflammatory bowel disease and its RESPONSE to tumour necrosis factor (TNF) inhibitors TREATMENT
Official title: Spondyloarthropathy in Inflammatory Bowel Disease Patients and Evaluation of Its Response to TNF Inhibitors in Assiut University Hospital
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-10
Completion Date
2026-03
Last Updated
2024-09-19
Healthy Volunteers
No
Interventions
TNF inhibitors
tumour necrosis factor inhibitors approved as treatments for ulcerative colitis and/or Crohns disease
conventional ibd medical treatment
Conventional therapies for ulcerative colitis and Crohns disease (CD) include aminosalicylates, corticosteroids, thiopurines, methotrexate other than anti-tumor necrosis factor agents.